Aug 11 (Reuters) - scPharmaceuticals Inc SCPH.O :
* SCPHARMACEUTICALS INC. REPORTS SECOND QUARTER 2021
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* SCPHARMACEUTICALS - ENDED Q2 WITH CASH, CASH EQUIVALENTS,
RESTRICTED CASH, INVESTMENTS OF $90.2 MILLION, SUFFICIENT TO
FUND OPERATIONS AS CURRENTLY PLANNED INTO 2023
* SCPHARMACEUTICALS INC - LOWERED 2021 NET LOSS GUIDANCE TO
$30.0
TO $34.0 MILLION
* SCPHARMACEUTICALS INC QTRLY LOSS PER SHARE $0.26
Source text for Eikon: ID:nGNX3DBjnL
Further company coverage: SCPH.O
((Reuters.Briefs@thomsonreuters.com;))